IMITREX
Active substance: sumatriptan
INJECTION · SUMATRIPTAN SUCCINATE 6 mg/.5mL
United StatesActive
Marketing holder: GlaxoSmithKline LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- SUMATRIPTAN SUCCINATE · 6 mg/.5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 42 |
|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-29e2-7744-bdf5-51bd8ace5200,01a1208c-3117-7ebc-bfd4-d33d95cdcc5a,01a1208c-3740-7256-a690-ea500b452fbd,01a1208c-3b3f-70d8-b677-358c22880a91,01a1208c-41c1-74f1-837d-7edcddc29d5f;count=119 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0173-0478
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0173-0478 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0173-0478 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0173-0478 · Verified 2026-10-09 · open in source